Funded Tech Companies
Affinia Therapeutics
Wondering who provided funding to Affinia Therapeutics? Eli Lilly and Company, GV and Alexandria Venture Investments joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Affinia Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
43 Foundry Ave. 120
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Website
Email Address
Company Background Information
Overview
At Affinia Therapeutics, our purpose is to develop gene therapies that can have a transformative impact on people affected by devastating genetic diseases. Our proprietary platform enables us to methodically engineer novel AAV vectors and gene therapies that have remarkable tissue targeting and other properties.
Last Transaction
10/8/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Company Investors
- Eli Lilly and Company
- GV
- Alexandria Venture Investments
- Avidity Partners
- Mass General Brigham Ventures
- Atlas Venture (David Grayzel)
- New Enterprise Associates (Ed Mathers)
- F-Prime Capital (Robert Weisskoff)
- Perceptive Advisors
- Lonza Group AG
- Farallon Capital Management
- Octagon Investments Fund
- TCG Crossover
- EcoR1 Capital Management (Caroline Stout)
- RA Capital
- Casdin Capital
- Woodline Partners
- Mass General Brigham Innovation
- Partners Innovation Fund
Browse more funded tech companies:
Affini-T Therapeutics | Affinimark Technologies
Share this article
About Our VC Transaction Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs








